SCHEMBL21472972

SCHEMBL21472972

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4cccc5c6ccc7c8ccccc8c8cccc9c8c7c6n9c45)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.40
KMT2A Q03164 8/20 0.40
MAPT P10636 6/20 0.40
HPGD P15428 6/20 0.40
ALDH1A1 P00352 5/20 0.40
NTSR1 P30989 1/20 0.40
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
GLA P06280 1/20 0.39
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
FLT3 P36888 2/20 0.35
BMX P51813 1/20 0.35
CYP2C19 P33261 2/20 0.34
ACACA Q13085 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
MAPK10 P53779 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21473101 0.93 MEN1 (0.34) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21473079 0.91 MEN1 (0.36) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21472961 0.89 HPGD (0.41) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21473092 0.86 TSHR (0.35) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21461880 0.86 MAPK14 (0.34) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL21472987 0.86 CDK4 (0.35) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21472964 0.81 MEN1 (0.35) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21472988 0.81 PRKDC (0.33) MEN1KMT2AMAPTHPGDKDM4E
SCHEMBL21472969 0.81 ALDH1A1 (0.31) HPGDALDH1A1
SCHEMBL21472966 0.80 MEN1 (0.35) MEN1KMT2AMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190315759-A1 HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315759-A1 HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES OSBP, OSBP2, OSBPL3 MEN1 2886/4885KMT2A 4482/4885MAPT 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.